Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Journal of Clinical Investigation, 116 (7), 1776-1783
Tired of me-too suppliers
Tirzepatide is sold as Zepbound for chronic weight management and as Mounjaro for type 2 diabetes, working as a dual GLP-1/GIP receptor agonist that targets both the GLP-1 and GIP receptors instead of GLP-1 alone, which enhances fat metabolism and insulin sensitivity beyond a single-receptor peptide
Our peptides are commonly used in research involving: All products are intended for research use only and are not for human or animal consumption, therapeutic use, or clinical application
For a complete overview of MOTS-c's mechanism and biology, see the MOTS-c peptide profile
Brown University Health Blog Team
